Nice one. ESPR appears to be testing the uptrend line off that lone candle from March 20, 2017 (log scaling) with negative divergence on the indicators. I’ve set a price alert for a break below that TL & might take it if the biotech sector confirms at the time. Thx for passing it along. Here’s my daily chart with some targets.

I can see the potential for a bounce in the biotechs off this downtrend line in LABD which is also an uptrend line in both XBI (1x non-leveraged biotech ETF) & LABU. However, I’d prefer to wait for this primary uptrend line on XBI to go with conviction to re-short the biotechs for a potential longer-term swing trade. In fact, I might short LABU which is what I did back when the biotechs topped in mid-2015 & went on to experience their worst bear market in many years, if not decades, even falling more than they did during the 2007-2009 bear market: https://rightsideofthechart.com/biotech-wreck-pending-video/

I shorted LADU back then to take advantage of both the drop in the biotechs as well as the decay from the 3x leverage & excessive volatility in the biotechs & will likely do the same again once I am confident that the sector has likely topped. Again, a long here could work & seems objective as you’d be buying at support but I view it as trying to pick up nickels in front of a steamroller & as such, would prefer to wait for the next objective shorting opp.